News
Mallinckrodt to Present at UBS Global Healthcare Conference
Mallinckrodt Pharmaceuticals a leading global specialty biopharmaceutical company, will present on Tuesday, May 24, 2016, at the UBS Global Healthcare Conference at the Grand...
Industry Reports
Bayer interim report for the first quarter shows a successful start of 2016
Bayer interim report for the first quarter shows a successful start of 2016Substantial sales growth at Pharmaceuticals / Earnings expand in all segments /...
Industry Reports
Baxter Provides Updated Financial Outlook for 2016
Positive Sales Mix and Disciplined Expense Management Contribute to Strong First Quarter Performance; Adjusted Earnings Per Share were $0.36; First-quarter GAAP Earnings Per Share...
News
Amgen To Participate In The 2016 World Medical Innovation Forum™ On Cancer
Amgen announced plans to participate in the World Medical Innovation Forum™ on cancer held April 25-27, 2016, in Boston. The World Medical Innovation Forum...
Press Releases
CSL Celebrates 100 Years of Operation
Australia’s largest and most successful biotechnology company, CSL, will officially celebrate 100 years of operation on 25th April 2016. World pharma...
Research Insight
AbbVie, CytomX to co-develop for Probody Drug Conjugates
AbbVie and CytomX Therapeutics, Inc announced that they have entered into a collaboration to co-develop and co-commercialize Probody™ Drug Conjugates against CD71, also...
Research Insight
OFIRMEV (Acetaminophen) Injection Health Economic Data Presented and Specially Recognized at Annual Congress of Enhanced Recovery and Perioperative Medicine
Mallinckrodt plc a leading global specialty biopharmaceutical company announced the results from a retrospective analysis of health economic data on the use of OFIRMEV...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read